Table 1.
Included (869) | Excluded (63) | p | |
---|---|---|---|
Pretreatment TSH (mU/L) | 1.75±0.94 | 2.88±4.2 | <0.0001 |
Sex (male) | 59.3% | 47.7% | 0.07 |
Ethnicity (white/other) | 54.9%/45.1% | 55.6%/44.4% | 0.92 |
Smoking (current) | 37.2% | 38.1% | 0.88 |
Iodine excess | 58.9% | 61.9% | 0.64 |
Age (years) | 44.3±11.3 | 46.9±10.3 | 0.08 |
Body mass index | 25.9±4.9 | 26.9±5.5 | 0.17 |
Genotype 2 | 45.7% | 47.6% | 0.77 |
Sustained viral response | 81.2% | 85.7% | 0.38 |
Fibrosis (none/severe) | 80.3%/6.5% | 87.1%/3.2% | 0.19 |
Duration of infection (years) | 4.5±5.5 | 5.0±5.3 | 0.52 |
Duration of therapy (weeks) | 23.1±3.6 | 23.2±3.2 | 0.90 |
Excluded subjects were not different from the included euthyroid subjects except in having a higher rate of abnormal TSH (a specific exclusion criteria). Values are proportions, or means and standard deviation. All p-values represent the results of a proportion test or two-sided T-test as appropriate.
TSH, thyrotropin.